Since 1987, Oxford University Innovation has been responsible for creating spinout companies based on academic research generated within and owned by the University of Oxford, and in recent years has spun out 15-20 new companies every year.
Over £2.5bn in external investment has been raised by Oxford University Innovation spinouts since 2010, and ten of our current portfolio are currently listed in London and New York.
The creation of new spinout companies, most of which are listed below, also channels millions of pounds back into University research, benefits local economic development and has created many new jobs in the region.
Surface Therapeutics is a drug discovery and development company developing innovative new drugs to treat inflammatory epithelial diseases of the skin and lungs. Surface Therapeutics was acquired by Serentis Inc in September 2007.
Incorporated in November 2004
Origin: Oxford University, Wellcome Trust Centre for Human Genetics
Neurodegenerative diseases.
Incorporated in March 1998
Origin: Oxford University, Department of Pathology
Pharmaceuticals.
Incorporated in January 1998
Origin: Oxford University, Department of Engineering Science
TdeltaS is committed to developing science-based proprietary products that sit at the interface of food and pharmaceuticals - nutraceuticals - and offer real improvement in human physical and mental performance.
Incorporated in March 2006
Origin: Oxford University, Department of Physiology, Anatomy and Genetics
Pre-clinical stage biotechnology company which aims to deliver innovative cancer care to patients.
Incorporated in December 2017
Origin: Oxford University
Contact: Adam Workman
A software development company that produce clinical trial data. In 2005 Third Phase Ltd merged with the Cmed Group Ltd. Third Phase Limited Merges with Cmed Group October 2005.
Incorporated in January 2000
Origin: Oxford University, Department of Engineering Science
Kepler Energy Limited develops a second-generation tidal turbine, which has the potential to harness tidal energy more efficiently and cheaply, using a device which is simpler, more robust and more scalable than current designs.
Incorporated in October 2010
Origin: Oxford University, Department of Engineering Science
Immunology.
Incorporated in December 2000
Origin: Oxford University, Department of Pathology
Echo Machine Learning Assay
Incorporated in May 2017
Origin: Oxford University, Radcliffe Department of Medicine
The company has been formed around two viral vector vaccines, one to prevent influenza and the other to treat prostate cancer.
Incorporated in March 2016
Origin: Oxford University, Jenner Institute
Velocys, previously Oxford Catalysts, produces speciality catalysts for the generation of clean fuels, from both conventional fossil fuels and renewable sources such as biomass.
Incorporated in December 2005
Origin: Oxford University, Department of Chemistry
Domain-centric intelligent automated data extraction methodology.
Incorporated in February 2015
Origin: Oxford University, Department of Computer Science
Nanoparticles for cancer therapy, imaging and drug delivery.
Incorporated in August 2015
Origin: Oxford University, Department of Engineering Science
YASA Motors manufactures a highly differentiated advanced axial flux motor and generator based on its proprietary Yokeless And Segmented Armature (YASA™) technology.
Incorporated in August 2009
Origin: Oxford University, Department of Engineering Science
Data discovery software to manage and sort collections of images and data visually.
Incorporated in January 2016
Origin: Oxford University, Sir William Dunn School of Pathology
Modification of proteins.
Incorporated in May 2002
Origin: Oxford University, Department of Chemistry
